SE9600716L - Adhesionsinhibitorer, preparat innehållande desamma och förfarande för framställning därav - Google Patents

Adhesionsinhibitorer, preparat innehållande desamma och förfarande för framställning därav

Info

Publication number
SE9600716L
SE9600716L SE9600716A SE9600716A SE9600716L SE 9600716 L SE9600716 L SE 9600716L SE 9600716 A SE9600716 A SE 9600716A SE 9600716 A SE9600716 A SE 9600716A SE 9600716 L SE9600716 L SE 9600716L
Authority
SE
Sweden
Prior art keywords
products
lactobacillus strains
preparation
strains producing
biological activity
Prior art date
Application number
SE9600716A
Other languages
English (en)
Other versions
SE508045C2 (sv
SE9600716D0 (sv
Inventor
Patricia Lynne Conway
Arthur Ouwehand
Original Assignee
Arla Ekonomisk Foerening
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arla Ekonomisk Foerening filed Critical Arla Ekonomisk Foerening
Priority to SE9600716A priority Critical patent/SE508045C2/sv
Publication of SE9600716D0 publication Critical patent/SE9600716D0/sv
Priority to EP97906380A priority patent/EP0904091A1/en
Priority to PCT/SE1997/000313 priority patent/WO1997030717A1/en
Priority to AU21089/97A priority patent/AU2108997A/en
Priority to CA 2243067 priority patent/CA2243067A1/en
Publication of SE9600716L publication Critical patent/SE9600716L/sv
Publication of SE508045C2 publication Critical patent/SE508045C2/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE9600716A 1996-02-26 1996-02-26 Adhesionsinhibitorer, preparat innehållande desamma och förfarande för framställning därav SE508045C2 (sv)

Priority Applications (5)

Application Number Priority Date Filing Date Title
SE9600716A SE508045C2 (sv) 1996-02-26 1996-02-26 Adhesionsinhibitorer, preparat innehållande desamma och förfarande för framställning därav
EP97906380A EP0904091A1 (en) 1996-02-26 1997-02-25 Adhesion inhibitors, preparation comprising them and method for producing them
PCT/SE1997/000313 WO1997030717A1 (en) 1996-02-26 1997-02-25 Adhesion inhibitors, preparation comprising them and method for producing them
AU21089/97A AU2108997A (en) 1996-02-26 1997-02-25 Adhesion inhibitors, preparation comprising them and method for producing them
CA 2243067 CA2243067A1 (en) 1996-02-26 1997-02-25 Adhesion inhibitors, preparation comprising them and method for producing them

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9600716A SE508045C2 (sv) 1996-02-26 1996-02-26 Adhesionsinhibitorer, preparat innehållande desamma och förfarande för framställning därav

Publications (3)

Publication Number Publication Date
SE9600716D0 SE9600716D0 (sv) 1996-02-26
SE9600716L true SE9600716L (sv) 1997-08-27
SE508045C2 SE508045C2 (sv) 1998-08-17

Family

ID=20401546

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9600716A SE508045C2 (sv) 1996-02-26 1996-02-26 Adhesionsinhibitorer, preparat innehållande desamma och förfarande för framställning därav

Country Status (5)

Country Link
EP (1) EP0904091A1 (sv)
AU (1) AU2108997A (sv)
CA (1) CA2243067A1 (sv)
SE (1) SE508045C2 (sv)
WO (1) WO1997030717A1 (sv)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001010448A1 (en) * 1999-08-09 2001-02-15 University Of Maryland, Baltimore Pro-gut maturation and anti-inflammatory effects of lactobacillus and lactobacillus secreted proteins, carbohydrates and lipids
GB201112091D0 (en) 2011-07-14 2011-08-31 Gt Biolog Ltd Bacterial strains isolated from pigs
GB201117313D0 (en) 2011-10-07 2011-11-16 Gt Biolog Ltd Bacterium for use in medicine
GB201306536D0 (en) 2013-04-10 2013-05-22 Gt Biolog Ltd Polypeptide and immune modulation
PL3065748T3 (pl) 2014-12-23 2018-07-31 4D Pharma Research Limited Szczep Bacteroides thetaiotaomicron i jego zastosowanie w zmniejszaniu zapalenia
KR20170091157A (ko) 2014-12-23 2017-08-08 4디 파마 리서치 리미티드 피린 폴리펩티드 및 면역 조정
MD3650033T2 (ro) 2015-06-15 2022-08-31 4D Pharma Res Ltd Compoziții conţinând tulpini bacteriene
EA201890050A1 (ru) 2015-06-15 2018-06-29 4Д Фарма Рисёрч Лимитед Композиции, содержащие бактериальные штаммы
SI3240554T1 (sl) 2015-06-15 2019-12-31 4D Pharma Research Limited, Blautia stercosis in wexlerae za uporabo v zdravljenju vnetnih in avtoimunskih bolezni
MA41010B1 (fr) 2015-06-15 2020-01-31 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
MA41060B1 (fr) 2015-06-15 2019-11-29 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
GB201520497D0 (en) 2015-11-20 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
AU2016357554B2 (en) 2015-11-20 2019-04-04 Cj Bioscience, Inc. Compositions comprising bacterial strains
GB201520638D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520631D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
EP3520801A1 (en) 2016-03-04 2019-08-07 4D Pharma Plc Compositions comprising bacterial blautia strains for treating visceral hypersensitivity
GB201612191D0 (en) 2016-07-13 2016-08-24 4D Pharma Plc Compositions comprising bacterial strains
TW201821093A (zh) 2016-07-13 2018-06-16 英商4D製藥有限公司 包含細菌菌株之組合物
GB201621123D0 (en) 2016-12-12 2017-01-25 4D Pharma Plc Compositions comprising bacterial strains
JP7212945B2 (ja) 2017-05-22 2023-01-26 フォーディー ファーマ リサーチ リミテッド 細菌株を含む組成物
TW201907931A (zh) 2017-05-24 2019-03-01 英商4D製藥研究有限公司 包含細菌菌株之組合物
WO2018229188A1 (en) 2017-06-14 2018-12-20 4D Pharma Research Limited Compositions comprising bacterial strains
CN115813955A (zh) 2017-06-14 2023-03-21 4D制药研究有限公司 包含细菌菌株的组合物
MD3804737T2 (ro) 2017-06-14 2022-10-31 4D Pharma Res Limited Compoziții care conțin tulpini bacteriene

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8900546D0 (sv) * 1989-02-17 1989-02-17 Bioinvent Int Ab Medel foer inhibering av patogeners adhesion tillvaext och /eller oeverlevnad

Also Published As

Publication number Publication date
EP0904091A1 (en) 1999-03-31
SE508045C2 (sv) 1998-08-17
SE9600716D0 (sv) 1996-02-26
AU2108997A (en) 1997-09-10
WO1997030717A1 (en) 1997-08-28
CA2243067A1 (en) 1997-08-28

Similar Documents

Publication Publication Date Title
SE9600716D0 (sv) Adhesion inhibitors, preparation comprising them and method for producing them
CA1246445A (en) Intestinal microflora-improving agent
JP3055940B2 (ja) 非光合成で不稔の糸状細菌のエンベロープ又はエンベロープの或る部分を含有する医薬生成物、特に免疫調整用医薬生成物及びその製造
TR200101049T2 (tr) Siklik tetrapeptid bileşiği ve kullanımı
NO931085L (no) Tarmkanal-koloniserende lactobasiller
DE69425671D1 (de) Glucosamin-disaccharide, verfahren zu deren herstellung, pharmazeutische präparate davon und ihre verwendung
BR9809921A (pt) Método para admistração de composição de microorganismos viáveis para aves domésticas
ATE407687T1 (de) Probiotisches milchsäurebakterium zur behandlung bakterieller infektionen in zusammenhang mit sids
MY116272A (en) Immunity enhancing lactic acid bacteria
CA1266234A (en) Method of binding microflora
DE3766200D1 (de) L-dopa enthaltendes arzneimittel.
NO975366L (no) Vaksine sammensetning inneholdende polyribosylribitol fosfat og fremgangsmåte for fremstilling derav
CH692199A8 (fr) Composes pyridiques et compositions pharmaceutique
Grand‐Perret et al. Macrophage activation by trehalose dimycolate requirement for an expression signal in vitro for antitumoral activity; biochemical markers distinguishing primed and fully activated macrophages
SE9704584L (sv) Framställning av konjugerad linolsyra
JPH05219942A (ja) 細菌クロストリジウム・ヒストリチカムの変異株、その製造法及びその用途
AU2420001A (en) Methods and compositions for the treatment of pain
CA2131681A1 (en) Antitumor agent
ES8505722A1 (es) Procedimiento para preparar un polisacarido hipotrigliceridemicamente activo
GR3004863T3 (sv)
EP0856519A3 (en) Antibacterial insect protein
EP1132383A4 (en) NEW AGAROFURAN DERIVATIVES, THEIR PRODUCTION, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND THEIR USE AS MEDICINE
CA1286623C (en) Liver function-improving agent and blood pressure- lowering agent
JPH0699314B2 (ja) マクロフア−ジ活性化剤
ATE108480T1 (de) Ws-9326 a, ws-9326b und deren derivate.

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 9600716-6

Format of ref document f/p: F